Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
FABP5 encodes the fatty acid binding protein found in epidermal cells, and was first identified as being upregulated in psoriasis tissue. Additionally we are shipping FABP5 Proteins (11) and FABP5 Kits (6) and many more products for this protein.
Showing 10 out of 51 products:
Human Polyclonal FABP5 Primary Antibody for ELISA, WB - ABIN108515
Maeda K,Uysal KT,Makowski L,Gorgun CZ,Atsumi G,Parker RA,Bruning J,Hertzel AV,Bernlohr DA,Hotamisligil GS: Role of the fatty acid binding protein mal1 in obesity and insulin resistance. in Diabetes 2003
Show all 3 references for 108515
Following infection with Listeria monocytogenes, we observed similar clonal expansion, contraction and formation of memory CD8 (show CD8A Antibodies) T cells in WT and E-FABP (show FABP5L1 Antibodies)-/- mice. Analysis of Listeria-specific CD4 (show CD4 Antibodies) T cells revealed no defect in the expansion, contraction, and formation of memory CD4 (show CD4 Antibodies) T cells in E-FABP (show FABP5L1 Antibodies)-/- mice. Our data demonstrate that E-FABP (show FABP5L1 Antibodies) is dispensable for antigen-specific T cell response following bacterial infection.
Genetic deletion of fatty acid-binding protein 5 (FABP5) in mice reduces uptake of exogenous docosahexaenoic acid (DHA) into brain endothelial cells and brain capillaries and reduces brain parenchymal levels of endogenous DHA. Therefore, FABP5 in the brain endothelial cell is a crucial contributor to the brain levels of DHA. Critically, lowered brain DHA levels in FABP5(-/-) mice occurred in tandem with cognitive deficits
the balance between FABP4 (show FABP4 Antibodies) and FABP5 in endothelial cells may be important in regulation of angiogenic versus quiescent phenotypes in blood vessels.
Mice lacking FABP5 and FABP7 (show FABP7 Antibodies), which exhibit highest affinities for endocannabinoids, possessed elevated levels of the endocannabinoid anandamide and the related N-acylethanolamines palmitoylethanolamide and oleoylethanolamide.
These studies show, for the first time, a correlation between FABP5 and EGFR (show EGFR Antibodies) in enhancing TNBC metastasis through a novel mechanism
loss of FABP5 promotes a more anti-inflammatory response.
Circulating levels of GIP (show GIP Antibodies) were significantly decreased in FABP5-deficient mice.
The frameshift and missense mutations in FABP3 (show FABP3 Antibodies), FABP5, and FABP7 (show FABP7 Antibodies) genes have been identified in schizophrenia and autism spectrum disorder in humans and in mouse behavioral studies.
FABP5 contributes to the development of Diet-induced obesity in a gastric inhibitory polypeptide (show GIP Antibodies)-dependent manner.
Data indicate that epidermal fatty acid binding protein (E-FABP (show FABP5L1 Antibodies))-immunoreactivity was found in the entire cytoplasm and on the mitochondrial outer membrane.
A high expression ratio between FABP5 and CRABPII (show CRABP2 Antibodies) may be related to CP tumor recurrence and ATRA could be a potential therapeutic agent for CP chemotherapy.
Data suggest that antinociceptive agent SBFI-26 binds at a portal site as well as at the canonical site in the substrate pocket of FABP5 and FABP7 (show FABP7 Antibodies); only the S form of SBFI-26 binds to both FABP5 and FABP7 (show FABP7 Antibodies) in their co-crystal structures; SBFI-26 induces conformational changes in FABP5 and FABP7 (show FABP7 Antibodies).
secreted FABP4 (show FABP4 Antibodies) and FABP5 from adipocytes as adipokines differentially affect transcriptional and metabolic regulation in ADSC near adipocytes
FABP5 plays an important role in the carcinogenesis and metastasis of cervical cancer, and FABP5 may be a novel predictor for prognostic assessment of cervical cancer patients.
FABP5 promoted VEGF (show VEGFA Antibodies) expression and angiogenesis through PPARgamma (show PPARG Antibodies) which was activated by fatty acids transported by FABP5.
FABP5 is associated with increased subclinical atherosclerosis
Long chain fatty acids suppress the oncogenic properties of FABP5-expressing carcinoma cells in cultured cells.
silencing of Sp1 (show PSG1 Antibodies), c-Myc (show MYC Antibodies) or FABP5 expression led to a significant decrease in cell proliferation, indicating that up-regulation of FABP5 expression by Sp1 (show PSG1 Antibodies) and c-Myc (show MYC Antibodies) is critical for the proliferation of prostate cancer cells
FABP5 may contribute to the airway remodeling and inflammation in asthma by fine-tuning the levels of CysLTs, which induce VEGF production.
This gene encodes the fatty acid binding protein found in epidermal cells, and was first identified as being upregulated in psoriasis tissue. Fatty acid binding proteins are a family of small, highly conserved, cytoplasmic proteins that bind long-chain fatty acids and other hydrophobic ligands. FABPs may play roles in fatty acid uptake, transport, and metabolism. Polymorphisms in this gene are associated with type 2 diabetes. The human genome contains many pseudogenes similar to this locus.
epidermal-type fatty acid-binding protein
, epithelial fatty acid-binding protein
, fatty acid-binding protein, epidermal
, keratinocyte lipid-binding protein
, psoriasis-associated fatty acid-binding protein homolog
, fatty acid binding protein 5
, differentiation-associated lipid-binding protein LP2
, epidermal fatty acid-binding protein
, fatty acid-binding protein 5
, cutaneous fatty acid-binding protein